Evidence map›Paper›PMID 41890479›Full record

ArticleCureus2026

Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy and Its Radiological Manifestations: A Case Report.

Azwade Rahman, Avraham Y Bluestone

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Azwade RahmanDiagnostic Radiology, Stony Brook University, Stony Brook, USA.
Avraham Y BluestoneRadiology: Neuroradiology, Stony Brook University Hospital, Stony Brook, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal astrocytes rely on a cytoskeletal element known as glial fibrillary acidic protein (GFAP), which facilitates their main structural framework, maintaining neurological function, repair, and lastly the blood-brain barrier. Pathologies such as neoplasms, autoimmune-mediated inflammation, and even genetic dysfunction can directly harm this element and result in malfunctioning astrocytes, CNS inflammation, and cell death. In this case report, we will create a timeline from presentation to remission of a rare entity known as autoimmune GFAP astrocytopathy for a middle-aged male with a wide variety of exposures and concomitant conditions. This case is unique, as in many cases, only one antibody marker was found on CSF analysis. After careful review of imaging from our institutional PACS, select slices were anonymized and organized here for review. The study aims to highlight the timeline of imaging features and their evolution. Advanced imaging techniques were also present and contributed to previous supporting evidence. Prior studies describe this entity with a wide variety of imaging features. Its most unique feature may be radial perivascular enhancement. What was not previously known is when these findings may present and how their absence within the time period of imaging may impact the investigation.

Indexed as

astrocytopathyautoimmune glial fibrillary acid protein astrocytopathy gfapautoimmun encephalitisgfapglial fibrillary acidic proteinhelminth infectionmeningo-encephalitismicroglia and astrocyte dysfunctionneuroradiologytoxic exposure

Identifiers

PMID41890479
PMCPMC13016709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.